United States

People: INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

20 Sep 2017
Change (% chg)

$-0.11 (-1.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kapoor, John 

Dr. John N. Kapoor, Ph.D. serves as Non-Independent Director of the Company. He has served on our Board since our formation in 1990. Since our formation, Dr. Kapoor also served as Chairman of the Board until he stepped down in January 2017. Dr. Kapoor also served as our President and Chief Executive Officer from November 2015 to January 2017. Dr. Kapoor also served as a director of Insys Pharma from its inception in 2002. Dr. Kapoor has served as the President and chairman of the board of directors of EJ Financial Enterprises since forming the company in 1990. Dr. Kapoor is also the Managing Partner of Kapoor-Pharma Investments, an investment company that he founded in 2000. Dr. Kapoor serves as the chairman of the board of directors of Akorn, Inc., a publicly traded specialty pharmaceutical company, where he previously served as the interim Chief Executive Officer from March 2001 to May 2002 and as chief executive officer from May 2002 to December 2002. Dr. Kapoor also served as the chairman of the board of directors of Sciele Pharma and OptionCare, a specialty pharmaceutical services company, where he served as Chief Executive Officer from August 1993 to April 1996. Dr. Kapoor received his Ph.D. in Medicinal Chemistry from the State University of New York at Buffalo and a B.S. in Pharmacy from Bombay University in India.

Basic Compensation

Total Annual Compensation, USD 546,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 4,745
Fiscal Year Total, USD 550,745

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --